Science Explorer Back to mapMap
Discussion
Researcher · Brigham and Women's Hospital · United States

Michael E. Weinblatt

Michael E. Weinblatt publishes mostly in Rheumatology, Hematology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research and Spondyloarthritis Studies and Treatments.

ORCID 0000-0001-5215-5512 OpenAlex
World rank
#29,535
of 7,710,434 ranked researchers
Rank in United States
#11,155
of 1,627,098
Works
533
Citations
55k
Citations per work
104.0
h-index
100
i10-index 282Top 0.3% in Rheumatology
Michael E. Weinblatt

What does Michael E. Weinblatt research?

Michael E. Weinblatt's work is mostly in Medicine (58%), Immunology and Microbiology (6%).

Health Sciences: 311 works · 58.3% of their workMedicine: 311 works · 58.3% of their workRheumatology: 201 works · 37.8% of their workHematology: 38 works · 7.2% of their workGenetics: 25 works · 4.6% of their workPathology and Forensic Medicine: 25 works · 4.6% of their workRadiology, Nuclear Medicine and Imaging: 22 works · 4.1% of their workEverything else: 189 works · 35.5% of their workLife Sciences: 33 works · 6.2% of their workImmunology and Microbiology: 33 works · 6.2% of their workImmunology: 33 works · 6.2% of their workTHEIR WORKMichael E.Weinblatt533works
Life Sciences6%Health Sciences58%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine31158.3%
  2. Everything else18935.5%
    1. Immunology and Microbiology336.2%
  1. 1Rheumatology38% of their works
  2. 2Hematology7% of their works
  3. 3Immunology6% of their works
  4. 4Pathology and Forensic Medicine5% of their works
  5. 5Genetics5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Michael E. Weinblatt's research?

The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Rituximab, Ankylosing Spondylitis, Hemophagocytic Lymphohistiocytosis, Juvenile Idiopathic Arthritis and Spondyloarthritis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Autoantibodies4482 topics
  2. Inflammation3601 topic
  3. Rheumatoid Arthritis3601 topic
  4. Rituximab1082 topics
  5. Ankylosing Spondylitis921 topic
  6. Hemophagocytic Lymphohistiocytosis921 topic
  7. Juvenile Idiopathic Arthritis921 topic
  8. Spondyloarthritis921 topic
  9. Monoclonal Antibodies912 topics
  10. Antiphospholipid Syndrome881 topic
  11. Systemic Lupus Erythematosus881 topic
  12. Chronic Lymphocytic Leukemia651 topic
  13. Genomic Aberrations651 topic
  14. Fc Receptors521 topic
  15. Therapeutic Antibodies521 topic
  16. Classification431 topic
  17. Lymphoma431 topic
  18. Biosimilars391 topic
  19. Immunogenicity391 topic

Where does Michael E. Weinblatt work?

Michael E. Weinblatt's main affiliation in the publication record is Brigham and Women's Hospital, United States.

How many publications and citations does Michael E. Weinblatt have?

OpenAlex counts 533 works and 55,416 citations for Michael E. Weinblatt, an h-index of 100, ranking #29,535 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael E. Weinblatt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.